Magnetic nanop articles for use in a pharmaceutical composition

TL;DRAbstract

[EN] The invention relates to a
\npharmaceutical composition that includes a magnetic
\nnanoparticle and at least one active ingredient,
\npreferably an antineoplastic or immunomodulator, for
\ntreating illnesses, in particular cancer. The nucleus of
\nthe magnetic nanoparticle includes a magnetic iron
\nAA oxide. The surface of the nanoparticle includes ligands
\n'c".,,,' BB bonded thereto by means of an ionic bond, a covalent bond, a hydrogen bridge, a hydrophobic bond, an
\nelectrostatic bond and/or a metal-ligand coordination
\nbond, wherein the ligand includes an active region
\nhaving at least one group chosen from - C02H, -P03H,
\n-P04H, -S03H and -S04H. Moreover, the active
\ningredient is bonded to the active region of the ligands
\nby means of ionic bonds.

Chat with Paper

AI Agents for this Paper